Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q2 2024 · 10-Q
Revenue$2.87M$2.87M−4.5% vs Q2 2023 Net Income-$76.32K-$76.32KN/M vs Q2 2023 EPS Diluted-$0.01-$0.01— vs Q2 2023 Operating Income-$70,524N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$344,086N/M Margins · derivedOperating margin-2.5%−2.5 pt vs Q2 2023
Net margin-2.7%−2.5 pt vs Q2 2023
ended Dec 31, 2023 · filed Feb 14, 2024 · 45 d after period end